Scarica l'app Stockscreener
1.93
3.76%
0.07
Dopo l'orario di chiusura:
1.96
0.03
+1.55%
Precedente Chiudi:
$1.86
Aprire:
$1.87
Volume 24 ore:
234.38K
Relative Volume:
0.22
Capitalizzazione di mercato:
$188.40M
Reddito:
$34.16M
Utile/perdita netta:
$-50.62M
Rapporto P/E:
-3.7992
EPS:
-0.508
Flusso di cassa netto:
$703.00K
1 W Prestazione:
+14.20%
1M Prestazione:
+40.88%
6M Prestazione:
-47.55%
1 anno Prestazione:
-47.12%
Intervallo 1D:
$1.81
$1.93
Intervallo di 1 settimana:
$1.655
$1.93
Portata 52W:
$1.22
$4.96
Omniab Inc Stock (OABI) Company Profile
Nome
Omniab Inc
Settore
Industria
Telefono
510-250-7800
Indirizzo
5980 HORTON STREET, EMERYVILLE
Confronta OABI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.93 | 188.40M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-04-21 | Iniziato | The Benchmark Company | Buy |
| 2023-04-13 | Iniziato | Craig Hallum | Buy |
| 2023-02-22 | Iniziato | Cowen | Outperform |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-20 | Iniziato | Truist | Buy |
| 2022-12-16 | Iniziato | Credit Suisse | Outperform |
| 2022-11-29 | Iniziato | SVB Leerink | Outperform |
| 2022-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Omniab Inc Borsa (OABI) Ultime notizie
OmniAb Elects Directors at Annual Shareholder Meeting - TipRanks
OmniAb shareholders elect two directors at annual meeting - Investing.com
OmniAb Inc Inc. (OABI) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Squarepoint Ops LLC - Defense World
Millennium Management LLC Buys 61,993 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
June 2025's Promising Penny Stocks to Consider - Yahoo Finance
OmniAb, Inc. (NASDAQ:OABI) Stake Cut by Jane Street Group LLC - Defense World
AI Is Rewiring Healthcare Faster Than Expected — Investors Are Hunting for Public Winners Now - The Globe and Mail
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.025 per Common Limited Partner Unit - The Globe and Mail
OmniAb, Inc. (NASDAQ:OABI) Shares Purchased by ProShare Advisors LLC - Defense World
BNP Paribas Financial Markets Buys Shares of 17,549 OmniAb, Inc. (NASDAQ:OABI) - Defense World
Bank of America Corp DE Has $2.18 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia
OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass - insights.citeline.com
OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada
OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister
Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st
Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance
51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World
Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World
Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus
Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks
Insider Buying: Steven Love Acquires 25,000 Shares of OmniAb Inc (OABI) - GuruFocus
Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks
Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com
Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World
OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha
OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN
OmniAb : May 2025 Corporate Overview - marketscreener.com
Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st
Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail
OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb Introduces the xPloration® Partner Access Program - BioSpace
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa
Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com
OmniAb Reports Steady Growth in Q1 2025 - TipRanks
Omniab Inc Azioni (OABI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omniab Inc Azioni (OABI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Love Steven | Director |
May 14 '25 |
Buy |
1.46 |
25,000 |
36,500 |
38,333 |
| HIGGINS JOHN L | Director |
May 12 '25 |
Buy |
1.44 |
65,000 |
93,600 |
2,831,887 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '25 |
Option Exercise |
0.00 |
36,458 |
0 |
3,815,618 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '25 |
Sale |
2.00 |
19,382 |
38,764 |
3,796,236 |
| Berkman Charles S | Chief Legal Officer |
Apr 07 '25 |
Option Exercise |
0.00 |
13,542 |
0 |
370,418 |
| Berkman Charles S | Chief Legal Officer |
Apr 07 '25 |
Sale |
2.00 |
7,206 |
14,412 |
363,212 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Apr 07 '25 |
Option Exercise |
0.00 |
13,542 |
0 |
231,034 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Apr 07 '25 |
Sale |
2.00 |
7,206 |
14,412 |
223,828 |
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):